Provided by Tiger Trade Technology Pte. Ltd.

Redhill Biopharma

0.5462
-0.0318-5.50%
Volume:322.94K
Turnover:182.19K
Market Cap:3.32M
PE:-4.02
High:0.5917
Open:0.5450
Low:0.5450
Close:0.5780
52wk High:2.14
52wk Low:0.4351
Shares:6.08M
Float Shares:6.08M
Volume Ratio:0.13
T/O Rate:5.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1358
EPS(LYR):-0.1358
ROE:-1708.61%
ROA:-22.37%
PB:-3.08
PE(LYR):-4.02

Loading ...

RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst

TIPRANKS
·
Jun 10

RedHill Biopharma's Opaganib Gains FDA Rare Pediatric Disease Status for Neuroblastoma

MT Newswires Live
·
Jun 09

RedHill says FDA grants opaganib rare pediatric disease designation for neuroblastoma

Reuters
·
Jun 09

RedHill Biopharma launches enforcement of $11M judgment against Kukbo

TIPRANKS
·
Jun 08

Redhill Biopharma Advances Opaganib Options For Ebola Virus Disease Outbreak

Reuters
·
Jun 04

RedHill Biopharma discusses adding opaganib to WHO Ebola trial platform

Reuters
·
Jun 04

RedHill Biopharma - Actively Discussing Potential Collaborations For Advancement Of Its Investigational Oral Drug, Opaganib

Reuters
·
Jun 02

RedHill Biopharma explores opaganib entry into WHO SOLIDARITY CORE Ebola trial platform

Reuters
·
Jun 02

RedHill Biopharma boosts maximum size of ATM ADS offering with H.C. Wainwright

Reuters
·
May 28

RedHill Biopharma releases corporate presentation on GI, infectious disease and oncology pipeline

Reuters
·
May 17

RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline

Reuters
·
Apr 29

Redhill Biopharma FY EPS $0.00, Sales $286.000K Down From $8.043M YoY

Benzinga Earnings
·
Apr 27

RedHill Biopharma FY25 operating loss widens to USD 7.9 million; revenue rises to USD 286,000

Reuters
·
Apr 27

RedHill Biopharma announces presentation of preclinical data on opaganib at AACR

TIPRANKS
·
Apr 22

RedHill Biopharma publishes corporate presentation on GI, infectious disease and oncology pipeline

Reuters
·
Apr 20

RedHill Biopharma gets Nasdaq notice after ADS bid price stays below $1

Reuters
·
Apr 14